FDA Approved: MYFEMBREE — Supplemental Application (Sumitomo Pharma America, Inc)

View source ↗

Summary

FDA approved a supplemental application for MYFEMBREE, a fixed-dose combination of relugolix with estradiol hemihydrate and norethindrone acetate. The sponsor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• MYFEMBREE (relugolix, estradiol hemihydrate, and norethindrone acetate)

Snippet

SUPPL AP for MYFEMBREE (RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE)